Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: Effects of scatter correction and tracer specific activity

Journal of Nuclear Medicine

Volumn 44, Issue 5, 2003, Pages 815-822

  Alexoff, David L ^a   Vaska, Paul ^a   Marsteller, Douglas ^b   Gerasimov, Timofei ^a   Li, Juan ^b   Logan, Jean ^a   Fowler, Joanna S ^a   Taintor, Nicholas B ^a   Thanos, Panayotis K ^a   Volkow, Nora D ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Dopamine receptor; MicroPET; Raclopride; Rat brain

Indexed keywords

CARBON 11; DOPAMINE 2 RECEPTOR; RACLOPRIDE; TRACER; CARBON; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DISTRIBUTION; IMAGE ANALYSIS; LIGHT SCATTERING; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; ANIMAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; MALE; METABOLISM; RADIATION SCATTERING; SPRAGUE DAWLEY RAT;

ANIMALS; CARBON RADIOISOTOPES; MALE; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; REPRODUCIBILITY OF RESULTS; SCATTERING, RADIATION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0038282711     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Tai YC, Chatziioannou A, Siegel S, et al. Performance evaluation of the microPET P4. a PET system dedicated to animal imaging Phys Med Biol. 2001;46: 1845-1862.
2. Jeavons AP, Chandler RA, Dettmar CAR. A 3D HIDAC-PET camera with sub-millimetre resolution for imaging small animals IEEE Trans Nucl Sci. 1999;46:468-473
3. Hume SP, Jones T. Positron emission tomography (PET) methodology for small animals and its application in radiopharmaceutical preclinical investigation. Nucl Med Biol 1998;25:729-732.
4. Burns HD, Hamill TG, Eng W, Francis B, Fioravanti C, Gibson RE. Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development Curr Opin Chem Biol. 1999;3:388-394.
5. Hume SP, Myers R. Dedicated small animal scanners: a new tool for drug development? Curr Pharm Des. 2002;8:1497-1511
6. Chatziioannou AF. Molecular imaging of small animals with dedicated PET tomographs. Eur J Nucl Med. 2002;29:98-114.
7. Hume SP, Lammertsma AA, Myers R, et al. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. J Neurosci Methods. 1996;67:103-112.
8. 11C]N- methylspiperone. Nucl Med Biol. 2002;29:307-316
9. 2 receptors and energy metabolism detected by in vivo micropet imaging in a rat model of Huntington's disease Exp Neurol. 2000;166: 287-297.
10. 2 receptors in the rat brain: an in vivo study using positron emission tomography. J Neurosci. 1996;16:7670-7677.
11. 11C-raclopride and microPET. J Nucl Med. 2002;43:1570-1577.
12. Budinger TF, Benaron DA, Koretsky AP Imaging transgenic animals. Annu Rev Biomed Eng. 1999;1:611-648
13. Opacka-Juffry J, Ashworth S, Ahier RG, Hume SP. Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET J Neural Transm. 1998, 105 349-364
14. 18F-(N-methyl)benpendol. J Nucl Med. 2001;42:1691-1696.
15. 2 receptors in the rat striatum by positron emission tomography. Synapse. 2002;43:195-200.
16. 11C]raclopride binding in rat striatum, quantified using PET. Synapse. 1995;21:45-53.
17. Meyers R, Hume SP, Ashworth S, et al. Quantification of dopamine receptors and transporter in rat striatum using a small animal PET scanner. In: Meyers R, Cunningham V, Bailey D, Jones T, eds. Quantification of Brain Function Using PET. London, U.K.: Academic Press. Inc ; 1996:12-15.
18. Farde L, Hall H, Ehrin E, Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science. 1986;231:258-261.
19. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coorindates 2nd ed. London, UK.: Academic Press; 1986.8-15.
20. Bloomfield PM, Myers R, Hume SP, Spinks TJ, Lammertsma AA, Jones T. Three-dimensional performance of a small-diameter positron emission tomograph. Phy Med Biol 1997;42:389-400.
21. Cherry SR, Huang S-C. Effects of scatter on model parameters in 3D PET studies of the human brain. IEEE Trans Nucl Sci. 1995;42:1174-1179.
22. Logan J, Fowler JS, Volkow ND, et al Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16:834-840.
23. Hume SP, Gunn RN, Jones T Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur J Nucl Med. 1998;25:173-176.
24. Hoffman EJ, Phelps ME. Positron emission tomography: principles and quantitation In: Phelps ME, Mazziotta JC, Scheiben HR, eds. Positron Emission Tomography and Autoradiography Principles and Applications for the Brain and Heart New York. NY: Raven Press: 1986:237-286
25. Kuge Y, Minemastsu K, Hasegawa Y, et al Positron emission tomography for quantitative determination of glucose metabolism in normal and ischemic brains in rats: an insoluble problem by the hardenan glands. J Cereb Blood Flow Metab. 1997;17:116-120.
26. Moore AH, Osteen CL, Chatziioannou AF, Hovda DA, Cherry SR. Quantitative assessment of longitudinal metabolic changes in vivo after traumatic brain injury in the adult rat using FDG-microPET. J Cereb Blood Flow Metab. 2000;20:1492-1501.
27. Fukuyama H, Hayashi T, Katsumi Y, Tsukada H, Shibasaki H Issues in measuring glucose metabolism of rat brain using PET: the effect of harderian glands on the frontal lobe. Neurosci Lett. 1998;255:99-102
28. Kornblum HI, Araujo DM, Annala AJ, Tatsukawa KJ, Phelps ME, Cherry SR. In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET). Nature Biotech. 2000;18: 655-660.
29. Lammertsma AA, Hume SP, Myers R, Bloomfield PM, Rajeswaran S, Jones T RAT-PET a bridge between ex vivo animal and in vivo patient studies. In: Uemura K, Lassen NA, Jones T, Kanno I, eds. Quantification of Brain Function: Tracer Kinetics And Image Analysis in Brain PET Proceedings of Brain PET '93. Akita. Japan, May 29-31, 1993. International Congress Series 1030. Tokyo, Japan Elsevier Science Publishers: 1993:321-329.
30. Volkow ND, Fowler JS, Wang G-J, et al Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J Nucl Med. 1993;34:609-613.
31. 11C-raclopride and positron emission tomography. J Neurosci. 1992;12:3773-3780.
32. 11C]raclopride binding with no alterations in static dopamine concentrations in the slnatal extracelluar fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis. Synapse. 2000;37:95-103.
33. Meikle SR, Eberl S, Fulton RR, Kassiou M, Fulham MJ. The influence of tomograph sensitivity on kinetic parameter estimation in positron emission tomography imaging studies of the rat brain Nucl Med Biol 2000;27:617-625
34. Huang S-C, Phelps ME. Principles of tracer kinetic modeling in positron emission tomography and autoradiography. In. Phelps ME, Mazziotta JC, Schelbert HR, eds. Positron Emission Tomography and Autoradiography Principles and Applications for the Brain and Heart New York, NY: Raven Press; 1986:287-346
35. Morris ED, London ED. Limitations of binding potentials as a "clinical" measure of receptor function: susceptibility to mass. [abstract]. Neuroimage. 1997;5 B61